Covered recipient · General Payments record
EMILY K MILLER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$767.04
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $285.65 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $136.34 | 1 |
| Novo Nordisk AS | $99.18 | 6 |
| BECTON, DICKINSON AND COMPANY | $18.25 | 1 |
| Alkermes, Inc. | $17.48 | 1 |
| Arcutis Biotherapeutics, Inc. | $14.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $17.48 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120555235 | CMS |
| Arcutis Biotherapeutics, Inc. | $14.40 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121093553 | CMS |
| Becton, Dickinson and Company | $18.25 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127618985 | CMS |
| Novo Nordisk Inc | $14.05 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100651259 | CMS |
| Novo Nordisk Inc | $14.87 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100550204 | CMS |
| Novo Nordisk Inc | $18.80 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100463528 | CMS |
| Novo Nordisk Inc | $20.53 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100620706 | CMS |
| Novo Nordisk Inc | $14.53 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100309163 | CMS |
| Novo Nordisk Inc | $16.40 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100292657 | CMS |
| Teva Pharmaceuticals USA, Inc. | $136.34 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151567161 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.